Search Results

Bioymifi 10 mg  | Purity Not Available

TargetMol

Bioymifi is a novel and potent small-molecule activator of the TRAIL receptor DR5 in human cancer cells.

More Information Supplier Page

Ibudilast 10 mg  | Purity Not Available

TargetMol

Ibudilast(KC-404;AV-411;MN-166) is a relatively nonselective phosphodiesterase inhibitor. It is approved for use as an anti-inflammatory in Japan.

More Information Supplier Page

Bioymifi 5 mg  | Purity Not Available

TargetMol

Bioymifi is a novel and potent small-molecule activator of the TRAIL receptor DR5 in human cancer cells.

More Information Supplier Page

Bioymifi 25 mg  | Purity Not Available

TargetMol

Bioymifi is a novel and potent small-molecule activator of the TRAIL receptor DR5 in human cancer cells.

More Information Supplier Page